Fri.Oct 25, 2024

article thumbnail

Menopause and Beyond: Unlock the Power of Collagen for Lasting Health

Alison Bladh

Boost Your Health and Skin with Collagen During Menopause As we navigate the natural changes of menopause, supporting our body becomes more essential than ever. Collagen, a protein our bodies produce less of over time, plays a critical role in skin elasticity, joint health, and bone density. In fact, collagen supplements can be a powerful addition to your wellness routine, especially for women in their 40s and beyond.

Collagen 101
article thumbnail

Global Wellness Summit Reveals The Future of Wellness 2024 Trends Report

Skin Inc

Their trends team has been analyzing the wellness space and upcoming trends for more than 20 years. Here are the trends that GWS noticed took priority in 2024, and will revolutionize wellness for 2025 and beyond.

52
article thumbnail

U.S. Dermatology Partners Physician Recognized as Best Dermatologist in Chillicothe Constitution-Tribune’s Reader’s Choice Awards

US Dermatologt Partners

Chillicothe, Missouri – U.S. Dermatology Partners physician, Dr. Megan Lent , is named Best Dermatologist in the Chillicothe Constitution-Tribune’s Reader’s Choice Awards 2024! U.S. Dermatology Partners is Recognized in the Chillicothe Constitution-Tribune’s 2024 Reader’s Choice Awards U.S. Dermatology Partners is thrilled to congratulate Dr.

article thumbnail

Journal Digest: October 25

Dermatology Times

This review of the latest dermatologic studies includes discussions on the development of the Hand Eczema Impact Scale, the role of tofacitinib on Th1 and Th2 cytokines, and more.

Eczema 36
article thumbnail

One-on-One: TDD/JDNPPA Talks to Kristin Belleson, the National Eczema Association’s New President and CEO

The Dermatology Digest

As National Eczema Awareness Month 2024 draws to a close, TDD/JDNPPA sat down with Kristin Belleson, the new President and CEO of the National Eczema Association (NEA), to discuss the group’s upcoming education and advocacy initiatives, learn how healthcare providers can be more involved with the NEA, and get some intel on the coveted NEA Seal of Acceptance program.

Eczema 36
article thumbnail

The Rise of Popularity in Biostimulators

Aesthetic Advancements Institute (AAI)

As a practitioner in the field of medical aesthetics, staying ahead of trends is crucial for delivering the best outcomes for our patients. One of the most significant shifts we’re witnessing is the rise of biostimulatory injectables. These innovative treatments not only enhance our toolkit but also redefine how we approach skin rejuvenation, focusing on long-term skin health alongside immediate results.

More Trending

article thumbnail

Guselkumab Demonstrates Significant Skin Clearance in Hard-to-Treat Moderate Psoriasis Sites

Dermatology Times

Phase 3b study showed promise in clearing moderate PsO in sensitive areas for patients unresponsive to topical treatments.

article thumbnail

Devices Dermatologists Love Episode Three: Sciton’s BBL HEROic With Dr. Sherrif F. Ibrahim

The Dermatology Digest

Sherrif F. Ibrahim, MD, PhD, an Assistant Professor in the Department of Dermatology at the University of Rochester Medical Center in Rochester, NY, shares his enthusiasm for Sciton’s BBL HEROic , a workhorse broadband light device that he uses to address pigmentation, vascularity, and skin quality on the face, chest, and arms. The post Devices Dermatologists Love Episode Three: Sciton’s BBL HEROic With Dr.

Medical 36
article thumbnail

Available Therapeutics and Upcoming Advancements in Atopic Dermatitis and Prurigo Nodularis

Dermatology Times

Shawn Kwatra, MD, reviews key highlights of his sessions at Fall Clinical 2024 on the latest updates in itch conditions.

article thumbnail

Game-Changing Insights on Itch, Psoriatic Disease, and Innovations With Mona Shahriari, MD, FAAD

Dermatology Times

Shahriari highlighted advanced dermatology treatments, clinical trial inclusivity, and key care strategies for complex skin conditions at Fall Clinical 2024.

article thumbnail

The Latest in Dermatology With James Del Rosso, DO: Part 2

Dermatology Times

Del Rosso reviews available and upcoming monoclonal antibodies, including nemolizumab, lebrikizumab, bimekizumab, and more.

article thumbnail

Day 2 Recap: Fall Clinical 2024

Dermatology Times

Catch up on coverage from the second day of the 2024 Fall Clinical Dermatology Conference in Las Vegas, Nevada.

Clinic 36
article thumbnail

New LEVEL UP Period 2 Data Shows Patients Who Switched From Dupilumab to Upadacitinib Achieved Higher Treatment Targets in AD

Dermatology Times

Christopher Bunick, MD, PhD, presented the latest period 2 data at Fall Clinical 2024.

Clinic 41